SEC Company Response from ClearPoint Neuro, Inc. (CLPT) (CIK 0001285550) (CLPT) — Jun 16, 2016
ClearPoint Neuro, Inc. (CLPT) (CIK 0001285550)
Date: June 16, 2016 · CIK: 0001285550 · Accession: 0001534424-16-000824
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-211007
Letter
Re:
June 16, 2016
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
MRI Interventions, Inc.
Registration Statement on Form S-1/A
File No. 333-211007
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, MRI Interventions, Inc. (the “Company”) hereby respectfully requests acceleration of the effectiveness of the Company’s Registration Statement on Form S-1, File Number 333-211007, so that it will be declared effective on June 20, 2016 at 9:00 a.m. Eastern Time, or as soon as practicable thereafter.
This letter will confirm that the Company acknowledges that:
· should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Please contact our legal counsel, Richard F. Mattern, of Bass, Berry & Sims PLC, at (901) 543-5933, if you have any questions concerning this request.
Sincerely,
MRI Interventions,
Inc.
Show Raw Text
CORRESP
1
filename1.htm
June 16, 2016
VIA
EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
MRI Interventions, Inc.
Registration Statement on Form S-1/A
File No. 333-211007
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Ladies and Gentlemen:
In accordance with
Rule 461 under the Securities Act of 1933, as amended, MRI Interventions, Inc. (the “Company”) hereby respectfully
requests acceleration of the effectiveness of the Company’s Registration Statement on Form S-1, File Number 333-211007, so
that it will be declared effective on June 20, 2016 at 9:00 a.m. Eastern Time, or as soon as practicable thereafter.
This letter will confirm
that the Company acknowledges that:
· should the Securities and Exchange Commission (the “Commission”) or the staff,
acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action
with respect to the filing;
· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring
the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure
in the filing; and
· the Company may not assert staff comments and the declaration of effectiveness as a defense in
any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Please contact our
legal counsel, Richard F. Mattern, of Bass, Berry & Sims PLC, at (901) 543-5933, if you have any questions concerning this
request.
Sincerely,
MRI Interventions,
Inc.
By:
/s/ Harold A. Hurwitz
Name:
Harold A. Hurwitz
Title:
Chief Financial Officer and Secretary